Free tool
Oncology stocks
We cover 7 companies grouped under the Oncology theme. The median market value in the group is $669.65M. Across the group, the median move over the past trading day is +1.43%. Price change over the past year runs from −32.0% to +489.9% across the middle 80 percent of the group, with a median of +4.5%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
7 of 319 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| 2160.T | GNI Group Ltd. | 2,765.00 JPY | +12.58% | +20.74% | +4.54% |
| 4587.T | PeptiDream Inc. | 1,135.00 JPY | +22.00% | −29.98% | −28.26% |
| 4588.T | Oncolys BioPharma Inc. | 4,130.00 JPY | +65.80% | +176.44% | +526.71% |
| CU6.AX | Clarity Pharmaceuticals Ltd | 2.48 AUD | +16.98% | −33.15% | −27.91% |
| RAC.AX | Racura Oncology Ltd | 2.15 AUD | +5.39% | −25.09% | +72.00% |
| SPL.AX | Starpharma Holdings Limited | 0.74 AUD | −1.34% | +101.37% | +465.38% |
| 4889.T | Renascience Inc. | 1,378.00 JPY | −7.70% | −3.57% | −37.68% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.